Skip to main content
Equibles
ITGR logo

ITGR · Integer Holdings Corp

Track ITGR — free

Use ITGR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$125.31 -0.08 (-0.06%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.26B
Shares
33.99M

ITGR metrics

89 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$125.39
Market cap
$4.26B

Price action

19 metrics
Price change (1W)
+0.0%
Price change (30D)
+0.8%
Price change (3M)
+38.8%
Price change (6M)
+44.5%
Price change (YTD)
+59.9%
Price change (1Y)
+16.2%
Trailing year
Price change (5Y)
+26.5%
52-week high
$126.07
52-week low
$63.32
Change from 52-week high
-0.5%
Change from 52-week low
+98.0%
Annualized volatility
47.0%
Beta
0.7
RSI (14D)
80.1
Price vs SMA 50
+15.1%
Price vs SMA 200
+39.4%
Avg volume (3M)
866,732
Relative volume
1.4
Average dollar volume
$99.45M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
33.99M

Valuation

12 metrics
P / E (TTM)
34.1
Trailing earnings · reciprocal yield 2.9%
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 33.6%
EV / EBITDA
17.3×
reciprocal yield 5.8%
EV / EBIT
30.6×
reciprocal yield 3.3%
P / sales
2.3×
reciprocal yield 43.3%
P / book
2.5
reciprocal yield 40.3%
FCF yield
2.6%
TTM · current market cap
Buyback yield
—
P / FCF
38.1
reciprocal yield 2.6%
P / operating cash flow
20.7
reciprocal yield 4.8%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
37.2×
reciprocal yield 2.7%
P / E historical average (5Y)
36.1×
reciprocal yield 2.8%
EV / revenue historical average (3Y)
2.7×
reciprocal yield 36.8%
EV / revenue historical average (5Y)
2.7×
reciprocal yield 37.1%
EV / EBIT historical average (3Y)
24.1×
reciprocal yield 4.1%
EV / EBIT historical average (5Y)
25.5×
reciprocal yield 3.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
25.7%
Operating margin
9.7%
Trailing 12 months
Net margin
7.0%
Gross profit (TTM)
$473.45M
Operating profit (TTM)
$178.77M
Net income (TTM)
$128.40M
Trailing 12 months
Diluted EPS (TTM)
$3.68
FCF margin
6.1%
Effective tax rate
5.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$18.35

Growth

11 metrics
Revenue growth YoY
-2.6%
Year over year
Net income growth YoY
-36.2%
Revenue (TTM)
$1.84B
Trailing 12 months
EPS growth YoY
-33.7%
Shares change YoY
-4.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.7%
Revenue CAGR (5Y)
+11.5%
EPS CAGR (3Y)
+13.2%
EPS CAGR (5Y)
+4.4%
FCF CAGR (3Y)
+36.1%
FCF CAGR (5Y)
-4.8%

Quality

14 metrics
Return on equity
7.5%
Return on assets
3.8%
Debt / equity
0.7
Current ratio
3.7
EBITDA (TTM)
$316.87M
Free cash flow (TTM)
$111.98M
Quick ratio
2.4
Interest coverage
4.6
Net debt / EBITDA
3.8
Return on invested capital
5.7%
Trailing 12 months
Net cash
−$1.22B
Latest balance sheet
Cash & equivalents
$21.38M
Total assets
$3.42B
Total debt
$1.24B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$205.44M
Capital expenditures (TTM)
$93.46M
R&D (TTM)
$48.58M
SG&A (TTM)
$224.07M
Stock compensation (TTM)
$22.73M
R&D / revenue
2.6%
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
331
13F filer change QoQ
+6
Institutional ownership
122.4%

Short interest

3 metrics
Short interest
8.4%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1114483 CUSIP 45826H109 13F (30d) 248 filings 245 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)